VEGF, an angiogenic cytokine, binds VEGFR-2 on endothelial cells, activating PI3K/Akt and Raf/MEK/ERK pathways, thereby promoting endothelial migration, and MM cell survival and proliferation [112]. This evidence concerns the gene AKT1 and Miyoshi myopathy.